U.S. Biotech Stock News

The recent move in ZIM Integrated Shipping Services (ZIM) has been driven by a sharp upward revision in consensus EPS estimates and increased attention on its upcoming earnings release, putting the stock firmly on investor watchlists. See our latest analysis for ZIM Integrated Shipping Services. At a share price of US$25.01, ZIM Integrated Shipping Services has seen momentum cool over the past quarter, with its 90 day share price return down 4.10%, even as the year to date share price return...

ConocoPhillips (COP) is in focus as the company prepares to release its Q2 2026 earnings on August 6, with expectations shaped by higher WTI crude prices amid recent geopolitical tensions. See our latest analysis for ConocoPhillips. The recent run up in ConocoPhillips’ share price, with a 7 day share price return of 6.58% and 30 day return of 8.29%, comes after a period where the 90 day share price return declined 4.49%. At the same time, the 1 year total shareholder return of 29.13% and 5...

C.H. Robinson Worldwide recently reported its June 2026 quarter results, delivering year-over-year growth in both earnings and revenue despite earlier analyst caution about an earnings beat. The combination of stronger fundamentals and a previously negative Earnings ESP has highlighted how quickly sentiment can shift when expectations and outcomes diverge. With analysts’ expectations having turned more cautious ahead of this report, we’ll now examine how that shifting sentiment affects C.H...

FS Bancorp (FSBW) has just posted Q2 2026 results, with total revenue of US$36.2 million and basic EPS of US$1.08 on net income of US$7.9 million, while trailing 12 month figures sit at US$144.9 million of revenue and EPS of US$4.45. The company has seen revenue move from US$35.3 million in Q2 2025 to US$36.2 million in Q2 2026, with EPS shifting from US$1.00 to US$1.08 over the same period. This sets the stage for investors to weigh forecast earnings growth and dividend income against how...

Stride (LRN) has drawn attention after recent trading, with the stock last closing at US$84.22. For investors watching the education sector, the company’s performance metrics offer a snapshot of current market expectations. See our latest analysis for Stride. Recent trading has been mixed for Stride, with the latest 1 day share price return slipping 0.56%. At the same time, the year to date share price return sits at 30.35% and the 3 year total shareholder return is 122.10%, suggesting...

Teledyne Technologies (TDY) opened Q2 2026 with revenue of US$1,662.5 million and basic EPS of US$5.37, on top of trailing twelve month EPS of US$20.94 and revenue of US$6.4 billion that came with 13.5% earnings growth year over year. The company has seen revenue move from US$1,513.7 million and EPS of US$4.48 in Q2 2025 to US$1,662.5 million and EPS of US$5.37 in Q2 2026, while trailing net profit margin edged up from 14.5% to 15.3%. This sets up an earnings release where investors are...

Eli Lilly launched its FDA approved Alzheimer's drug Kisunla, adding a new treatment option to its neuroscience portfolio. The company is preparing prominent presentations at the 2026 Alzheimer's Association International Conference, highlighting its neuroscience pipeline. Eli Lilly is maintaining a leadership role in the AI driven Illumina Billion Cell Atlas alliance focused on large scale neurodegenerative research. Eli Lilly (NYSE:LLY) is drawing attention for activity beyond its GLP 1...

Altria Group’s stock has returned 123.0% over the past 5 years, and both its intrinsic value estimate using a Discounted Cash Flow (DCF) approach and its market multiples currently point to the shares screening as undervalued. This leaves investors to assess how durable that apparent discount really is. Over 5 years, Altria Group has delivered a 123.0% total return, which puts a spotlight on whether the current share price still leaves room relative to its assessed value. Regulatory...

Webull stock has rebounded in the short term, but with the share price at US$8.10 and the valuation checks pointing to a mixed picture while the market multiples lean expensive, investors are left weighing whether the recent weakness over the past year has already been fully priced in. Over the last 1 year, Webull has fallen 54.3%, which suggests sentiment around the stock has been materially weaker than its recent weekly and monthly gains might imply. The valuation outlook can be shaped by...

In the second quarter of 2026, Redwire Corporation received US$21.5 million in follow-on purchase orders for its Advanced Navigation Stalker Block 30 uncrewed aircraft systems from the U.S. Marine Corps, alongside recent factory expansions in Huntsville and a new space research facility in Georgetown, Indiana. By pairing expanded defense UAS production with a new hub for space-enabled pharmaceutical and biotech research, Redwire is pushing into an unusual combination of military and...

John Marshall Bancorp (JMSB) just posted Q2 2026 results with total revenue of US$18.5 million and basic EPS of US$0.50, set against trailing twelve month revenue of US$66.9 million and EPS of US$1.73 that came with earnings growth of 29.2% over the past year. Over recent quarters the company has seen revenue move from US$14.9 million and EPS of US$0.36 in Q2 2025 to US$18.5 million and EPS of US$0.50 in Q2 2026, while trailing net profit margins sit at 36.4% versus 33.2% in the prior year,...

Badger Meter (BMI) has just posted its Q2 2026 scorecard, with revenue of US$222.3 million, basic EPS of US$1.02 and net income of US$29.7 million framing the latest quarter. The company has seen quarterly revenue move between US$202.3 million and US$238.1 million over the past six periods, while basic EPS has ranged from US$0.94 to US$1.31. This sets the backdrop for a quarter where investors will be weighing a net margin that now sits at 14.3% against the recent slip from 15.5% to judge how...

CNA Financial recently reached a 52-week high, supported by strong premium growth, disciplined underwriting, and a balance sheet with capital above target levels. The insurer’s continued dividend increases, combined with growth across its Specialty, Commercial, and International segments, highlight how operational strength is reinforcing its long-term business profile. Next, we’ll examine how this underwriting strength and segment-wide premium growth color CNA Financial’s investment...

Wells Fargo (WFC) has drawn fresh attention after reporting robust second quarter results, with double digit growth in diluted earnings per share and revenue across all segments, alongside an 11% dividend increase following favorable Federal Reserve stress test outcomes. See our latest analysis for Wells Fargo. Despite the strong second quarter report and dividend increase, Wells Fargo’s 1 month share price return of 3.08% and 3 month share price return of 7.34% contrast with a year to date...

Earlier in July 2026, Sempra’s board appointed long-time company executive Justin C. Bird as future Executive Vice President and Chief Financial Officer, timed to the planned third-quarter closing of a partial sale of Sempra’s equity interest in Sempra Infrastructure Partners and coinciding with Karen L. Sedgwick’s move to lead Southern California Gas Company. This leadership reshuffle, paired with preparations to sell part of Sempra Infrastructure Partners, comes as analysts forecast solid...

Earlier this week, Zacks upgraded Exelon to a Rank #2 (Buy), citing rising earnings estimates and a more favorable outlook versus peers such as Pinnacle West. An interesting angle for investors is that Exelon’s stronger value metrics, including lower forward P/E and PEG ratios, are helping differentiate it within the regulated utilities space. We’ll now explore how this analyst upgrade and improving earnings outlook might influence Exelon’s existing investment narrative and risk-reward...

NOV earnings expectations set the stage for July 28 report Wall Street is bracing for lower earnings and revenue when NOV (NOV) reports June quarter results on July 28, with investor attention centering on whether the company can outperform these cautious expectations. See our latest analysis for NOV. At a share price of $20.33, NOV has seen a 23.89% year to date share price return and a 51.87% total shareholder return over the past year. This suggests positive recent momentum as investors...

Dividend affirmation and earnings expectations draw attention to Phillips 66 Phillips 66 (PSX) has reaffirmed its shareholder payout with a declared quarterly dividend of $1.27 per share, while investors also focus on the upcoming August 5, 2026 earnings report. The dividend is scheduled to be paid on September 1, 2026 to shareholders of record as of August 18, 2026. This provides current and prospective investors with clear timelines as they weigh income potential alongside earnings...

FirstEnergy (FE) is back in focus after the board declared a quarterly dividend of $0.465 per share and the company highlighted reliability gains from recent Jersey Central Power & Light infrastructure upgrades. See our latest analysis for FirstEnergy. At a share price of $49.33, FirstEnergy has shown steady momentum, with a 1 month share price return of 5.5% and a year to date share price return of 9.0%. The 1 year total shareholder return of 24.6% points to investors rewarding the dividend...

In Q1 2026, POET Technologies reported revenue growth of over 200% while contending with multiple class action lawsuits, a CEO departure, and a US$400 million dilutive equity offering. This surge in sales, tied to ramping 800G production in Malaysia and a Lumilens order that could become recurring, highlights how operational execution is influencing perceptions despite legal and leadership headwinds. Next, we’ll examine how this very large revenue increase and Malaysia 800G ramp shape POET...

Marathon Petroleum (MPC) is drawing attention after its stock outperformed major indices, gaining 1.41% in the latest session and rising 27.51% over the past month ahead of its August 4 earnings release. See our latest analysis for Marathon Petroleum. At a share price of $315.82, Marathon Petroleum has recently given investors a strong run, with a 30 day share price return of 27.71% and a year to date share price return of 91.24%. The 5 year total shareholder return is very large at more than...

After a strong multi year run, WisdomTree stock now faces a valuation tension, with the share price reflecting very robust past returns while the broad checks flag it as expensive rather than a clear bargain. WisdomTree has returned about 254% over the last 5 years, which sets a high bar for any further gains to be justified by future cash flow and earnings power. Recent attention on the company’s “modern alpha” ETF range, including new thematic and AI driven funds, can support optimism...

Thermo Fisher Scientific (TMO) is back in focus after ImmuPharma selected the company to develop and manufacture the finished drug product for its experimental diabetes treatment Kapiglucagon, following a competitive tender process. See our latest analysis for Thermo Fisher Scientific. The Kapiglucagon contract lands as Thermo Fisher Scientific’s recent share price has climbed, with a 30-day share price return of 13.46% and a 90-day gain of 12.80%. The year-to-date share price return is still...

How Stanley Black & Decker stock has been performing Stanley Black & Decker (SWK) has delivered a 25.95% total return over the past year, with gains of 3.41% over the past month and 17.42% over the past 3 months, based on recent performance figures. See our latest analysis for Stanley Black & Decker. At a share price of US$89.25, Stanley Black & Decker’s recent 7 day share price return of 1.47% and 90 day share price return of 17.42% point to building short term momentum, while the 1 year...